Immunotactoid glomerulopathy associated with monoclonal gammopathy. 2021

Satoshi Inotani, and Taro Horino, and Masayuki Ishihara, and Osamu Ichii, and Akinori Matsumori
Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kochi, Japan.

UI MeSH Term Description Entries
D007155 Immunologic Factors Biologically active substances whose activities affect or play a role in the functioning of the immune system. Biological Response Modifier,Biomodulator,Immune Factor,Immunological Factor,Immunomodulator,Immunomodulators,Biological Response Modifiers,Biomodulators,Factors, Immunologic,Immune Factors,Immunological Factors,Modifiers, Biological Response,Response Modifiers, Biological,Factor, Immune,Factor, Immunological,Factors, Immune,Factors, Immunological,Modifier, Biological Response,Response Modifier, Biological
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008870 Microtubules Slender, cylindrical filaments found in the cytoskeleton of plant and animal cells. They are composed of the protein TUBULIN and are influenced by TUBULIN MODULATORS. Microtubule
D008998 Monoclonal Gammopathy of Undetermined Significance Conditions characterized by the presence of M protein (Monoclonal protein) in serum or urine without clinical manifestations of plasma cell dyscrasia. Benign Monoclonal Gammopathies,Monoclonal Gammapathy of Undetermined Significance,Monoclonal Gammopathies, Benign,Monoclonal Gammapathies, Benign,Benign Monoclonal Gammapathies,Benign Monoclonal Gammapathy,Benign Monoclonal Gammopathy,Monoclonal Gammapathy, Benign,Monoclonal Gammopathy, Benign
D009404 Nephrotic Syndrome A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction. Childhood Idiopathic Nephrotic Syndrome,Frequently Relapsing Nephrotic Syndrome,Multi-Drug Resistant Nephrotic Syndrome,Pediatric Idiopathic Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndrome,Steroid-Resistant Nephrotic Syndrome,Steroid-Sensitive Nephrotic Syndrome,Multi Drug Resistant Nephrotic Syndrome,Nephrotic Syndrome, Steroid-Dependent,Nephrotic Syndrome, Steroid-Resistant,Nephrotic Syndrome, Steroid-Sensitive,Nephrotic Syndromes,Steroid Dependent Nephrotic Syndrome,Steroid Resistant Nephrotic Syndrome,Steroid Sensitive Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndromes,Steroid-Resistant Nephrotic Syndromes,Steroid-Sensitive Nephrotic Syndromes,Syndrome, Nephrotic,Syndrome, Steroid-Sensitive Nephrotic
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D005260 Female Females
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069283 Rituximab A murine-derived monoclonal antibody and ANTINEOPLASTIC AGENT that binds specifically to the CD20 ANTIGEN and is used in the treatment of LEUKEMIA; LYMPHOMA and RHEUMATOID ARTHRITIS. CD20 Antibody, Rituximab,GP2013,IDEC-C2B8,IDEC-C2B8 Antibody,Mabthera,Rituxan,IDEC C2B8,IDEC C2B8 Antibody,Rituximab CD20 Antibody

Related Publications

Satoshi Inotani, and Taro Horino, and Masayuki Ishihara, and Osamu Ichii, and Akinori Matsumori
January 2021, Journal of community hospital internal medicine perspectives,
Satoshi Inotani, and Taro Horino, and Masayuki Ishihara, and Osamu Ichii, and Akinori Matsumori
January 2022, Case reports in nephrology and dialysis,
Satoshi Inotani, and Taro Horino, and Masayuki Ishihara, and Osamu Ichii, and Akinori Matsumori
January 1996, American journal of nephrology,
Satoshi Inotani, and Taro Horino, and Masayuki Ishihara, and Osamu Ichii, and Akinori Matsumori
August 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Satoshi Inotani, and Taro Horino, and Masayuki Ishihara, and Osamu Ichii, and Akinori Matsumori
September 1990, Postgraduate medical journal,
Satoshi Inotani, and Taro Horino, and Masayuki Ishihara, and Osamu Ichii, and Akinori Matsumori
January 2009, Nature clinical practice. Nephrology,
Satoshi Inotani, and Taro Horino, and Masayuki Ishihara, and Osamu Ichii, and Akinori Matsumori
January 1998, American journal of nephrology,
Satoshi Inotani, and Taro Horino, and Masayuki Ishihara, and Osamu Ichii, and Akinori Matsumori
August 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Satoshi Inotani, and Taro Horino, and Masayuki Ishihara, and Osamu Ichii, and Akinori Matsumori
March 1991, American journal of kidney diseases : the official journal of the National Kidney Foundation,
Satoshi Inotani, and Taro Horino, and Masayuki Ishihara, and Osamu Ichii, and Akinori Matsumori
July 1985, Medicine,
Copied contents to your clipboard!